Essity Results Presentation Deck

Health & Medical Q2 2022 vs Q2 2021 ■ ■ ■ Strong organic sales growth Higher volumes, higher prices and better mix Significantly higher costs for raw material, energy and distribution (margin impact: -920bps) ▪ Price increases implemented and further increases during second half 2022 ΤΕΝΑ e9 ees e9 Leukoplast 1) Net sales which excludes exchange rate effects, acquisitions and divestments 2) Excluding items affecting comparability JOBST Actimove essity Half-year Report 2022 Net Sales SEK 6,145m +16.9% 3.9% 4.0% Volume Sales Growth ¹) (Organic & Acquisitions) Price/ Mix % Net Sales: +10.9% Organic: +7.9% 6.0% Adjusted EBITA²) Organic Sales Growth SEK 673m -29% 79% 15.4% Mature Emerging Markets Markets 21% Adjusted EBITA Margin ²) 11.0% -710bps 7.5% 8.5% Incontinence Medical Products Solutions Health Care 58% 42% July 21, 2022 9

View entire presentation